Online Only Articles

Vincristine, dexamethasone and epratuzumab for older relapsed/refractory CD22+ B-acute lymphoblastic leukemia patients: a phase II study

Hematology Department, CHU Hotel-Dieu, Nantes
Hematology Department, CHU, Toulouse
Hematology Department, Hôpital Saint-Louis, Paris
Hematology Department, Institut Paoli-Calmette, Marseille
Hematology Department, CHU, Bordeaux
Hematology Department, Hopital Saint-Antoine, Paris
Hematology/Biology Department, CHU Hotel-Dieu, Nantes, France
Hematology Department, CHU Hotel-Dieu, Nantes
Hematology Department, CHU Hotel-Dieu, Nantes
Hematology Department, Institut Paoli-Calmette, Marseille
Hematology Department, CHU, Bordeaux
Hematology Department, CHU Hotel-Dieu, Nantes
Hematology/Biology Department, CHU Hotel-Dieu, Nantes, France
Immunomedics, Inc., Morris Plains, NJ, USA
Immunomedics, Inc., Morris Plains, NJ, USA
Hematology Department, Hôpital Saint-Louis, Paris
Vol. 100 No. 4 (2015): April, 2015 https://doi.org/10.3324/haematol.2014.120220